Management of granulomatous amebic encephalitis: Laboratory diagnosis and treatment

Subhash Chandra Parija1, Kp Dinoop1, Hrudya Venugopal2

  • 1Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

Tropical Parasitology
|February 25, 2015
PubMed

Insights

Granulomatous amebic encephalitis is a severe CNS infection caused by free-living amoebae. Early diagnosis and multi-drug, multi-specialty treatment are vital for survival and reducing long-term effects.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Parasitology

Background:

  • Granulomatous amebic encephalitis (GAE) is a rare but fatal infection of the central nervous system (CNS).
  • It is caused by free-living amoebae, including Acanthamoeba spp., Balamuthia mandrillaris, and Sappinia pedata.
  • GAE typically affects immunocompromised individuals and presents with subacute to chronic symptoms, leading to a high mortality rate.

Purpose of the Study:

  • To highlight the diagnostic challenges and critical importance of early detection of GAE.
  • To emphasize the need for a comprehensive treatment approach for GAE.
  • To underscore the necessity of interdisciplinary collaboration for managing GAE.

Main Methods:

  • Review of clinical presentations and diagnostic considerations for GAE.
  • Analysis of current treatment strategies, including antimicrobial and surgical interventions.
  • Discussion of differential diagnoses that mimic GAE.

Main Results:

  • Radiological findings in GAE are often nonspecific, leading to misdiagnosis and delayed treatment.
  • Accurate diagnosis relies on high clinical suspicion and specialized laboratory testing.
  • Effective treatment requires a combination of multiple antimicrobial agents and potentially surgical intervention.

Conclusions:

  • Early and accurate diagnosis of GAE is crucial for improving patient outcomes.
  • Multidrug therapy targeting specific amoebic pathways is essential.
  • A multidisciplinary approach involving neurologists, infectious disease specialists, and surgeons is necessary to manage GAE effectively and reduce mortality and morbidity.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
750
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
927
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K